JAMA Netw Open. 2020;3(9):e2019722. doi:10.1001/jamanetworkopen.2020.19722
David O. Meltzer, MD, PhD1; Thomas J. Best, PhD2; Hui Zhang, PhD2; et alTamara Vokes, MD1; Vineet Arora, MD, MPP1; Julian Solway, MD1
Download the PDF from Vitamin D Life
University of Chicago, March 2020
Vitamin D measurement were made 2 to 52 weeks before COVID-19 test
X less likely to test positive at each Vitamin D level
- Question Is vitamin D status, reflecting vitamin D levels and treatment, associated with test results for coronavirus disease 2019 (COVID-19)?
- Findings In this cohort study of 489 patients who had a vitamin D level measured in the year before COVID-19 testing, the relative risk of testing positive for COVID-19 was 1.77 times greater for patients with likely deficient vitamin D status compared with patients with likely sufficient vitamin D status, a difference that was statistically significant.
- Meaning These findings appear to support a role of vitamin D status in COVID-19 risk; randomized clinical trials are needed to determine whether broad population interventions and interventions among groups at increased risk of vitamin D deficiency and COVID-19 could reduce COVID-19 incidence.
Importance Vitamin D treatment has been found to decrease the incidence of viral respiratory tract infection, especially in patients with vitamin D deficiency. Whether vitamin D is associated with coronavirus disease 2019 (COVID-19) incidence is unknown.
Objective To examine whether the last vitamin D status before COVID-19 testing is associated with COVID-19 test results.
Design, Setting, and Participants This retrospective cohort study at an urban academic medical center included patients with a 25-hydroxycholecalciferol or 1,25-dihydroxycholecalciferol level measured within 1 year before being tested for COVID-19 from March 3 to April 10, 2020.
Exposures Vitamin D deficiency was defined by the last measurement of 25-hydroxycholecalciferol less than 20 ng/mL or 1,25-dihydroxycholecalciferol less than 18 pg/mL before COVID-19 testing. Treatment changes were defined by changes in vitamin D type and dose between the date of the last vitamin D level measurement and the date of COVID-19 testing. Vitamin D deficiency and treatment changes were combined to categorize the most recent vitamin D status before COVID-19 testing as likely deficient (last level deficient and treatment not increased), likely sufficient (last level not deficient and treatment not decreased), and 2 groups with uncertain deficiency (last level deficient and treatment increased, and last level not deficient and treatment decreased).
Main Outcomes and Measures The outcome was a positive COVID-19 polymerase chain reaction test result. Multivariable analysis tested whether vitamin D status before COVID-19 testing was associated with testing positive for COVID-19, controlling for demographic and comorbidity indicators.
Results A total of 489 patients (mean [SD] age, 49.2 [18.4] years; 366 [75%] women; and 331 [68%] race other than White) had a vitamin D level measured in the year before COVID-19 testing. Vitamin D status before COVID-19 testing was categorized as likely deficient for 124 participants (25%), likely sufficient for 287 (59%), and uncertain for 78 (16%). Overall, 71 participants (15%) tested positive for COVID-19.
In multivariate analysis, testing positive for COVID-19 was associated with
- increasing age up to age 50 years (relative risk, 1.06; 95% CI, 1.01-1.09; P = .02);
- non-White race (relative risk, 2.54; 95% CI, 1.26-5.12; P = .009), and
- likely deficient vitamin D status (relative risk, 1.77; 95% CI, 1.12-2.81; P = .02)
- compared with likely sufficient vitamin D status.
Predicted COVID-19 rates in the deficient group were 21.6% (95% CI, 14.0%-29.2%) vs 12.2%(95% CI, 8.9%-15.4%) in the sufficient group.
Conclusions and Relevance In this single-center, retrospective cohort study, likely deficient vitamin D status was associated with increased COVID-19 risk, a finding that suggests that randomized trials may be needed to determine whether vitamin D affects COVID-19 risk.
COVID-19 treated by Vitamin D - studies, reports, videos as of July 29 included
- 21 trials (generally treatment, not prevention), +10 observational studies, +7 recommendations,
- +34 associations, +58 speculations, +20 videos,
- and has the following recent updates
- Hospital COVID-19 observation: 7X more likely to live if more than 20 ng of vitamin D– Nov 19, 2020
- Severe COVID-19 not fought by 200,000 IU of vitamin D - RCT Nov 18, 2020
- Higher vitamin D associated with fewer cases and deaths in India Nov 2020
- COVID-19 defeated 3x faster by 420,000 IU Vitamin D nanoemulsion – RCT Nov 12, 2020
- 2X fewer COVID-19 deaths observed if infrequent vitamin D (2X more deaths if daily dose) – UK Oct 20, 2020
- Vitamin D fighting COVID-19 meets all Bradford Hill Criteria - Nov 2020
- French National Academy recommended 100,000 IU of Vitamin D to elderly to fight COVID-19 - May 2020
- Chinese COVID-19 study – 80 pct of severe cases had low Vitamin D, all asymptomatic cases had OK Vit D – Oct 13, 2020
- Vitamin D and COVID-19 - observational studies found it helps, never hurts - Campbell Oct 31, 2020
- COVID-19 increased risks with low vitamin D: Infection 1.5 X, Hospitalization 1.8 X – meta-analysis Oct 2020
- COVID-19 lung death 4X more likely in Iran if less than 25 ng of vitamin D – Oct 30, 2020
- Evidence Regarding Vitamin D and Risk of COVID-19 and its Severity - Oct 27, 2020
- COVID-19 patients who happened to be taking Vitamin D did much better – Oct 27,2020
- 9X COVID-19 survival in nursing home if had 80,000 IU dose of vitamin D in previous month – Oct 2020
- COVID-19 fought by Vitamin D in 43 studies - Oct 15, 2020
- 15 studies indicating that Vitamin D fights COVID-19 - Dr. Grimes Oct 9, 2020
- 32X more likely to have severe-critical COVID-19 in Turkish hospital if Vitamin D deficient – Oct 5, 2020
- Vitamin D Cuts SARS-CoV-2 Infection Rate by Half Mercola Sept 28
- 47% lower SARS-CoV-2 positivity rate if > 50 ng vs < 20 ng
- 58% lower risk of testing positive for SARS-CoV-2 if > 30 ng vs < 30 ng
- 2X higher risk of hospitialization if <30 ng
- ICU patients got semi-activated Vitamin D - death rate dropped to 2% from 50%
- Virtually no COVID-19 cases in countries having more than 30 ng of Vitamin D - Sept 17, 2020
- Studies on Vitamin D and COVID-19 (11 categories) - Sept 20, 2020
- Rate of COVID-19 test positive is 40 pcnt lower if high vitamin D (192,000 people) - Holick Sept 2020
- 14.7 X more likely to die of COVID-19 if less than 12 ng of Vitamin D (185 Germans) – Sept 10, 2020
- Low D increases risk of infection. Dr. Fauci Sept 11
- "If you're deficient in vitamin D, that does have an impact on your susceptibility to infection. I would not mind recommending, and I do it myself, taking vitamin D supplements,..." 32 minutes into Instagram interview
- Dr. Fauci takes 6,000 IU of Vitamin D daily – Sept 2020
Click on chart for details
- COVID-19 defeated by activated Vitamin D in Spain - pilot RCT Aug 29, 2020
- WHO – Severe COVID-19 mortality reduced by hormones (should consider hormone D too) - Sept 2020
- Vitamin D in Prevention and Treatment of COVID-19 (16 reasons) – Sept 1, 2020
Search Google Scholar for COVID-19 Vitamin D 20,000 publications Oct 10, 2020